CN102131798A - 用作磷酸二酯酶10抑制剂的二取代的苯基化合物 - Google Patents
用作磷酸二酯酶10抑制剂的二取代的苯基化合物 Download PDFInfo
- Publication number
- CN102131798A CN102131798A CN2009801332872A CN200980133287A CN102131798A CN 102131798 A CN102131798 A CN 102131798A CN 2009801332872 A CN2009801332872 A CN 2009801332872A CN 200980133287 A CN200980133287 A CN 200980133287A CN 102131798 A CN102131798 A CN 102131798A
- Authority
- CN
- China
- Prior art keywords
- compound
- alkyl
- group
- cycloalkyl
- replaces
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 **c(cc1)ccc1-c1c(*)ccc(*)c1* Chemical compound **c(cc1)ccc1-c1c(*)ccc(*)c1* 0.000 description 4
- RBAKWRHCDXPKON-UHFFFAOYSA-N CS(c1c(-c(cc2)ccc2O)c(-c2ccncc2)ccc1)(=O)=O Chemical compound CS(c1c(-c(cc2)ccc2O)c(-c2ccncc2)ccc1)(=O)=O RBAKWRHCDXPKON-UHFFFAOYSA-N 0.000 description 1
- GOVIHBDBDXXIME-UHFFFAOYSA-N Cc(cc1-c2ccncc2)ccc1OC1OCCCC1 Chemical compound Cc(cc1-c2ccncc2)ccc1OC1OCCCC1 GOVIHBDBDXXIME-UHFFFAOYSA-N 0.000 description 1
- RRVIWESTUOJNLJ-UHFFFAOYSA-N Cc(cccc1-c(cc2)ccc2OCc2nc3ccccc3cc2)c1O Chemical compound Cc(cccc1-c(cc2)ccc2OCc2nc3ccccc3cc2)c1O RRVIWESTUOJNLJ-UHFFFAOYSA-N 0.000 description 1
- HFMUEUYXQOCZRY-UHFFFAOYSA-N Cc(cccc1-c2ccncc2)c1O Chemical compound Cc(cccc1-c2ccncc2)c1O HFMUEUYXQOCZRY-UHFFFAOYSA-N 0.000 description 1
- SQPBKWJDIVWGRW-UHFFFAOYSA-N Cc1cccc(-c2ccncc2)c1-c(cc1)ccc1OCc1nc(cccc2)c2cc1 Chemical compound Cc1cccc(-c2ccncc2)c1-c(cc1)ccc1OCc1nc(cccc2)c2cc1 SQPBKWJDIVWGRW-UHFFFAOYSA-N 0.000 description 1
- QOHQNQHRQZWSTF-UHFFFAOYSA-N Fc(cc1-c(cc2)ccc2OCc2nc3ccccc3cc2)ccc1OC1OCCCC1 Chemical compound Fc(cc1-c(cc2)ccc2OCc2nc3ccccc3cc2)ccc1OC1OCCCC1 QOHQNQHRQZWSTF-UHFFFAOYSA-N 0.000 description 1
- ORHVYRUNPFZDQL-UHFFFAOYSA-N N#Cc(cc1)cc(Br)c1OC1OCCCC1 Chemical compound N#Cc(cc1)cc(Br)c1OC1OCCCC1 ORHVYRUNPFZDQL-UHFFFAOYSA-N 0.000 description 1
- XXTYWNOLGCCWED-UHFFFAOYSA-N N#Cc1cccc(-c(cc2)ccc2OCc2nc3ccccc3cc2)c1-c1ccncc1 Chemical compound N#Cc1cccc(-c(cc2)ccc2OCc2nc3ccccc3cc2)c1-c1ccncc1 XXTYWNOLGCCWED-UHFFFAOYSA-N 0.000 description 1
- BYUCNRJHRVHHNT-UHFFFAOYSA-N Oc(ccc(Cl)c1)c1-c(cc1)ccc1OCc1nc2ccccc2cc1 Chemical compound Oc(ccc(Cl)c1)c1-c(cc1)ccc1OCc1nc2ccccc2cc1 BYUCNRJHRVHHNT-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Nutrition Science (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7559908P | 2008-06-25 | 2008-06-25 | |
| US61/075,599 | 2008-06-25 | ||
| US13885608P | 2008-12-18 | 2008-12-18 | |
| US61/138,856 | 2008-12-18 | ||
| PCT/US2009/048608 WO2009158467A2 (en) | 2008-06-25 | 2009-06-25 | Di-substituted phenyl compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102131798A true CN102131798A (zh) | 2011-07-20 |
Family
ID=41137470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009801332872A Pending CN102131798A (zh) | 2008-06-25 | 2009-06-25 | 用作磷酸二酯酶10抑制剂的二取代的苯基化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110224204A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2297131A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2011526294A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20110025984A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102131798A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009262150A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0914775A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2729220A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2011000177A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2011102587A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009158467A2 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116323560A (zh) * | 2020-08-04 | 2023-06-23 | 精密生物治疗有限责任公司 | 作为胆汁酸受体和白三烯半胱氨酰受体的选择性和/或双重调节剂的喹啉化合物 |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2776240C (en) * | 2009-10-30 | 2017-06-13 | Janssen Pharmaceutica Nv | Radiolabelled pde10 ligands |
| EP2423181A1 (en) | 2010-07-28 | 2012-02-29 | Prous Institute For Biomedical Research S.A. | Multitarget substituted biphenyl diol derivatives |
| JP6106603B2 (ja) | 2011-01-11 | 2017-04-05 | スノビオン プハルマセウトイカルス インコーポレイテッド | ヘテロアリール化合物及びその使用方法 |
| WO2012112946A1 (en) | 2011-02-18 | 2012-08-23 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
| US20120309796A1 (en) | 2011-06-06 | 2012-12-06 | Fariborz Firooznia | Benzocycloheptene acetic acids |
| GB201113538D0 (en) * | 2011-08-04 | 2011-09-21 | Karobio Ab | Novel estrogen receptor ligands |
| US9630976B2 (en) | 2012-07-03 | 2017-04-25 | Ono Pharmaceutical Co., Ltd. | Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes |
| AU2013289284B2 (en) * | 2012-07-09 | 2017-03-30 | Janssen Pharmaceutica Nv | Inhibitors of phosphodiesterase 10 enzyme |
| WO2014071044A1 (en) | 2012-11-01 | 2014-05-08 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
| US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| EP2860177A3 (en) * | 2013-09-20 | 2015-06-10 | Bayer Intellectual Property GmbH | Synthesis of functionalized arenes |
| US9200016B2 (en) | 2013-12-05 | 2015-12-01 | Allergan, Inc. | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) |
| NZ757081A (en) | 2017-03-16 | 2023-03-31 | Crinetics Pharmaceuticals Inc | Somatostatin modulators and uses thereof |
| US11608335B2 (en) | 2018-02-12 | 2023-03-21 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| CR20200464A (es) | 2018-03-08 | 2021-04-14 | Incyte Corp | Compuestos diólicos de aminopirazina como inhibidores de pi3k-y |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
| TWI852944B (zh) | 2018-09-18 | 2024-08-21 | 美商克林提克斯醫藥股份有限公司 | 生長抑制素(somatostatin)調節劑及其用途 |
| TWI841768B (zh) | 2019-08-14 | 2024-05-11 | 美商克林提克斯醫藥股份有限公司 | 非肽生長抑制素(somatostatin)5型受體激動劑及其用途 |
| KR102811543B1 (ko) | 2019-10-16 | 2025-05-23 | 삼성디스플레이 주식회사 | 유기 전계 발광 소자 및 유기 전계 발광 소자용 다환 화합물 |
| US11773076B2 (en) | 2021-02-17 | 2023-10-03 | Crinetics Pharmaceuticals, Inc. | Crystalline forms of a somatostatin modulator |
| AU2023396827A1 (en) | 2022-12-13 | 2025-06-19 | Crinetics Pharmaceuticals, Inc. | Somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1055925A (zh) * | 1990-04-19 | 1991-11-06 | 帝国化学工业公司 | 吡啶衍生物及其制备方法 |
| CN1058774A (zh) * | 1990-06-19 | 1992-02-19 | 明治制菓株式会社 | 血管紧张素ii拮抗性吡啶衍生物 |
| EP1541149A1 (en) * | 2002-06-26 | 2005-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Phosphodiesterase inhibitor |
| US20060122256A1 (en) * | 2004-12-03 | 2006-06-08 | Paul Gillespie | Biaryloxymethylarenecarboxylic acids as glycogen synthase activators |
| WO2008033455A2 (en) * | 2006-09-13 | 2008-03-20 | The Institutes For Pharmaceutical Discovery, Llc | Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2264710A (en) * | 1992-03-04 | 1993-09-08 | Merck & Co Inc | Quinoline and azaquinoline angiotensin ii antagonists incorporating a substituted biphenyl element |
| JP2009535394A (ja) * | 2006-05-02 | 2009-10-01 | ファイザー・プロダクツ・インク | Pde10阻害剤としての二環式ヘテロアリール化合物 |
-
2009
- 2009-06-25 CN CN2009801332872A patent/CN102131798A/zh active Pending
- 2009-06-25 CA CA2729220A patent/CA2729220A1/en not_active Abandoned
- 2009-06-25 RU RU2011102587/04A patent/RU2011102587A/ru not_active Application Discontinuation
- 2009-06-25 WO PCT/US2009/048608 patent/WO2009158467A2/en not_active Ceased
- 2009-06-25 EP EP09770999A patent/EP2297131A2/en not_active Withdrawn
- 2009-06-25 KR KR1020117001927A patent/KR20110025984A/ko not_active Ceased
- 2009-06-25 US US13/001,361 patent/US20110224204A1/en not_active Abandoned
- 2009-06-25 JP JP2011516646A patent/JP2011526294A/ja active Pending
- 2009-06-25 MX MX2011000177A patent/MX2011000177A/es not_active Application Discontinuation
- 2009-06-25 BR BRPI0914775A patent/BRPI0914775A2/pt not_active IP Right Cessation
- 2009-06-25 AU AU2009262150A patent/AU2009262150A1/en not_active Abandoned
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1055925A (zh) * | 1990-04-19 | 1991-11-06 | 帝国化学工业公司 | 吡啶衍生物及其制备方法 |
| CN1058774A (zh) * | 1990-06-19 | 1992-02-19 | 明治制菓株式会社 | 血管紧张素ii拮抗性吡啶衍生物 |
| EP1541149A1 (en) * | 2002-06-26 | 2005-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Phosphodiesterase inhibitor |
| US20060122256A1 (en) * | 2004-12-03 | 2006-06-08 | Paul Gillespie | Biaryloxymethylarenecarboxylic acids as glycogen synthase activators |
| WO2008033455A2 (en) * | 2006-09-13 | 2008-03-20 | The Institutes For Pharmaceutical Discovery, Llc | Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116323560A (zh) * | 2020-08-04 | 2023-06-23 | 精密生物治疗有限责任公司 | 作为胆汁酸受体和白三烯半胱氨酰受体的选择性和/或双重调节剂的喹啉化合物 |
| CN116323560B (zh) * | 2020-08-04 | 2026-04-03 | 精密生物治疗有限责任公司 | 作为胆汁酸受体和白三烯半胱氨酰受体的选择性和/或双重调节剂的喹啉化合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0914775A2 (pt) | 2015-10-20 |
| AU2009262150A1 (en) | 2009-12-30 |
| MX2011000177A (es) | 2011-06-20 |
| JP2011526294A (ja) | 2011-10-06 |
| WO2009158467A2 (en) | 2009-12-30 |
| CA2729220A1 (en) | 2009-12-30 |
| KR20110025984A (ko) | 2011-03-14 |
| RU2011102587A (ru) | 2012-07-27 |
| EP2297131A2 (en) | 2011-03-23 |
| WO2009158467A3 (en) | 2010-07-29 |
| US20110224204A1 (en) | 2011-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102131801B (zh) | 1,2-二取代的杂环化合物 | |
| KR20110025984A (ko) | 포스포디에스테라제 10 억제제로서의 이치환된 페닐 화합물 | |
| CA2787360C (en) | Pyrrol0[3,2-c]pyridinyl-4-benzamide compounds and their use as apoptosis signal-regulating kinase 1 inhibitors | |
| RU2531274C2 (ru) | Феноксиметильные гетероциклические соединения | |
| CN103153996A (zh) | 作为激酶抑制剂的喹啉和喹喔啉衍生物 | |
| WO2020011246A1 (zh) | 含苯环的化合物、其制备方法及应用 | |
| US10160762B2 (en) | 6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors | |
| CN111808080B (zh) | 取代的吡啶或嘧啶化合物、其制备方法及其在医药上的应用 | |
| CN109305957B (zh) | 苯基吡啶类化合物及其在dpp-4酶抑制剂的应用 | |
| TW202400167A (zh) | 色胺酮衍生物及其用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20110720 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |